Drugs for Pneumocystosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 62)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Prednisolone phosphate |
Approved, Vet_approved |
Phase 4 |
|
302-25-0 |
|
Synonyms:
Prednisolone 21-(dihydrogen phosphate)
Prednisolone 21-monophosphate
|
Prednisolone 21-phosphate
|
|
2 |
|
Prednisolone acetate |
Approved, Vet_approved |
Phase 4 |
|
52-21-1 |
|
Synonyms:
ECONOPRED
FLO-PRED
METICORTELONE
NSC-10966
OMNIPRED
PRED FORTE
|
PRED FTE
PRED MILD
PREDNISOLONE 21-ACETATE
PREDNISOLONE ACETATE
STERANE
ULTRACORTENOL
|
|
3 |
|
Prednisolone |
Approved, Vet_approved |
Phase 4 |
|
50-24-8 |
4894 5755 |
Synonyms:
(11b)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
(11Β)-11,17,21-trihydroxypregna-1,4-diene-3,20-dione
1,4-Pregnadiene-11b,17a,21-triol-3,20-dione
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-11β,17α,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11b,17a,21-triol
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1,4-Pregnadiene-3,20-dione-11β,17α,21-triol
3,20-Dioxo-11b,17a,21-trihydroxy-1,4-pregnadiene
3,20-Dioxo-11beta,17alpha,21-trihydroxy-1,4-pregnadiene
3,20-Dioxo-11β,17α,21-trihydroxy-1,4-pregnadiene
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
Codelcortone
Co-Hydeltra
Cordrol
CORTALONE
Cotogesic
Cotolone
Decaprednil
Decortin H
DEKOTIL
Delcortol
Delta F
Delta(1)-Dehydrocortisol
Delta(1)-Dehydrohydrocortisone
Delta(1)-Hydrocortisone
DELTA.1-CORTISOL
DELTA.1-Cortisol|Orapred®|Pediapred®
Delta-Cortef
Deltacortenol
DELTACORTRIL
Deltacortril Enteric
delta-dehydrocortisol
delta-dehydrohydrocortisone
delta-hydrocortisone
Deltahydrocortisone
DELTALONE
Deltasolone
Delta-Stab
Deltisilone
Depo-Medrol
Derpo Pd
DESOWEN
Dexa-Cortidelt Hostacortin H
Di adreson F
Di-Adreson F
Di-adreson-F
DiAdresonF
Dicortol
DILACORT
Donisolone
Dydeltrone
Eazolin D
Econopred
Econopred Plus
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
FERNISOLONE-P
Flamasone
Hostacortin H
HYDELTRA
Hydeltrasol
HYDELTRA-TBA
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
IMS904
Inflamase Forte
Inflamase Mild
I-Pred
Key-Pred
Klismacort
Lentosone
Lite Pred
Medrol
|
Medrol Acetate
Metacortandralone
Methylprednisolone acetate
METICORTELONE
METI-DERM
Metreton
M-Predrol
NEO-DELTA-CORTEF
Nisolone
Nor-Pred T.B.A.
NSC-9120
NSC-9900
Ocu-Pred
Ocu-Pred Forte
Ophtho-Tate
ORAPRED
Panafcortelone
Paracortol
Paracotol
PEDIAPRED
PEVANTI
POLY-PRED
PRDL
Precortalon
Precortancyl
Precortilon
PRECORTISYL
PRECORTISYL FTE
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
PRED-G
Predisolone sodium phosphate
PREDL
Predne-Dome
Prednelan
Prednicen
Predni-Dome
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
Prednisolone
Prednisolone acetate
Prednisolone sodium phosphate
Prednisolone tebutate
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
PRELONE
Prenolone
Rolisone
SCHERIPROCT
Scherisolon
SERVISONE
Solone
Steran
STERANE
Sterolone
Supercortisol
TRIDESILON
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-Hydrogen
VERDESO
Δ(1)-dehydrocortisol
Δ(1)-dehydrohydrocortisone
Δ(1)-hydrocortisone
Δ-cortef
|
|
4 |
|
Methylprednisolone hemisuccinate |
Approved |
Phase 4 |
|
2921-57-5 |
1875 |
Synonyms:
Methylprednisolone hemisuccinate
Methylprednisolone hemisuccinic acid
|
Methylprednisolone hydrogen succinate
Methylprednisolone succinate
|
|
5 |
|
Methylprednisolone |
Approved, Vet_approved |
Phase 4 |
|
83-43-2 |
4159 6741 |
Synonyms:
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6Α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
1-Dehydro-6alpha-methylhydrocortisone
1-Dehydro-6a-methylhydrocortisone
1-Dehydro-6α-methylhydrocortisone
6 Methylprednisolone
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6a-Methyl-11b,17a,21-triol-1,4-pregnadiene-3,20-dione
6a-Methylprednisolone
6-Methylprednisolone
6Α-methyl-11β,17α,21-triol-1,4-pregnadiene-3,20-dione
6Α-methylprednisolone
Artisone-Wyeth
Besonia
Delta(1)-6alpha-Methylhydrocortisone
delta(1)-6a-Methylhydrocortisone
Dopomedrol
Esametone
Firmacort
J3.872E
Lemod
Medesone
Medixon
Medlone 21
Medrate
Medric acid
Medrol
Medrol Adt Pak
Medrol Dosepak
Medrol®|U-67590A
Medrone
Mesopren
|
Metastab
Methyleneprednisolone
Methylprednisolon
Methylprednisolone
Methylprednisolonum
Methylprednisolonum [INN-Latin]
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [Dcit]
Metipred
Metrisone
Metrocort
Metysolon
Moderin
Nirypan
Noretona
NSC-19987
Predni N Tablinen
Promacortine
Reactenol
Sieropresol
Solomet
SOLU-MEDROL
Summicort
Suprametil
U-67590A
Urbason
Urbasone
Wyacort
Δ(1)-6a-methylhydrocortisone
Δ(1)-6α-methylhydrocortisone
|
|
6 |
|
Sulfisoxazole |
Approved, Vet_approved |
Phase 4 |
|
127-69-5 |
5344 |
Synonyms:
3,4-Dimethyl-5-sulfanilamidoisoxazole
3,4-Dimethyl-5-sulfonamidoisoxazole
3,4-Dimethyl-5-sulphanilamidoisoxazole
3,4-Dimethyl-5-sulphonamidoisoxazole
3,4-Dimethylisoxazole-5-sulfanilamide
3,4-Dimethylisoxazole-5-sulphanilamide
4-Amino-N-(3,4-dimethyl-5-isoxazolyl)benzenesulfonamide
4-Amino-N-(3,4-dimethyl-5-isoxazolyl)benzenesulphonamide
5-(4-Aminophenylsulfonamido)-3,4-dimethylisoxazole
5-(4-Aminophenylsulphonamido)-3,4-dimethylisoxazole
5-(p-Aminobenzenesulfonamido)-3,4-dimethylisoxazole
5-(p-Aminobenzenesulphonamido)-3,4-dimethylisoxazole
5-Sulfanilamido-3,4-dimethylisoxazole
5-Sulfanilamido-3,4-dimethyl-isoxazole
5-Sulphanilamido-3,4-dimethylisoxazole
5-Sulphanilamido-3,4-dimethyl-isoxazole
Ammonium salt sulfisoxazole
Diolamine, sulfisoxazole
ENTUSIL
ERYZOLE
FNA brand OF sulfisoxazole
Gantrisin
Gantrisin pediatric
Monolithium salt sulfisoxazole
Monosodium salt sulfisoxazole
N(1)-(3,4-Dimethyl-5-isoxazolyl)sulfanilamide
N(1)-(3,4-Dimethyl-5-isoxazolyl)sulphanilamide
N'-(3,4)dimethylisoxazol-5-yl-sulfanilamide
N'-(3,4)dimethylisoxazol-5-yl-sulphanilamide
N1-(3,4-DIMETHYL-5-ISOXAZOLYL)SULFANILAMIDE
N1-(3,4-DIMETHYL-5-ISOXAZOLYL)SULPHANILAMIDE
NEAZOLIN
Neoxazoi
NSC-13120
NSC-683536
Pediatric, gantrisin
PEDIAZOLE
Roche brand OF sulfisoxazole
Roche brand OF sulfisoxazole acetate
Roche brand OF sulfisoxazole diolamine
SOSOL
SOXAZOLE
|
Sulfadimethylisoxazole
Sulfadimethyloxazole
Sulfafurazol
Sulfafurazol fna
Sulfafurazole
Sulfafurazolum
Sulfaisoxazole
SULFALAR
Sulfasoxazole
Sulfasoxizole
Sulfisonazole
Sulfisoxasole
Sulfisoxazol
SULFISOXAZOLE
Sulfisoxazole dialamine
Sulfisoxazole diolamine
Sulfisoxazole roche brand
Sulfisoxazole, ammonium salt
Sulfisoxazole, monolithium salt
Sulfisoxazole, monosodium salt
Sulfisoxazole, monosodium, monomesylate salt
Sulfisoxazole, triammonium salt
Sulfofurazole
Sulphadimethylisoxazole
Sulphafurazol
Sulphafurazole
Sulphafurazolum
Sulphaisoxazole
Sulphasoxazole
Sulphisonazole
Sulphisoxasole
Sulphisoxazol
Sulphisoxazole
Sulphofurazole
SULSOXIN
TL Azole
TL-Azole
Triammonium salt sulfisoxazole
V Sul
Vangard brand OF sulfisoxazole
V-Sul
Zenith brand OF sulfisoxazole
|
|
7 |
|
Prednisolone hemisuccinate |
Experimental |
Phase 4 |
|
2920-86-7 |
4897 |
Synonyms:
(+)-prednisolone hemisuccinate
4-(2-{14,17-dihydroxy-2,15-dimethyl-5-oxotetracyclo[8.7.0.0,.0,]heptadeca-3,6-dien-14-yl}-2-oxoethoxy)-4-oxobutanoate
Prednisolonbisuccinat
Prednisolone 21-hemisuccinate
Prednisolone 21-succinate
|
Prednisolone bisuccinate
PREDNISOLONE HEMISUCCINATE
Prednisolone hemisuccinic acid
Prednisolone hydrogen succinate
PREDNISOLONE SUCCINATE
|
|
8 |
|
Protective Agents |
|
Phase 4 |
|
|
|
9 |
|
Neuroprotective Agents |
|
Phase 4 |
|
|
|
10 |
|
Antiemetics |
|
Phase 4 |
|
|
|
11 |
|
Methylprednisolone Acetate |
|
Phase 4 |
|
|
584547 |
Synonyms:
Acetyl methylprednisolone
Acetyl-methylprednisolone
DEPMEDALONE
Depo medrol
Depo medrone
Depo-medrol
Depo-medrone
|
MEDROL ACETATE
Methylprednisolone 21 acetate
METHYLPREDNISOLONE ACETATE
Methylprednisolone acetate, (11beta,16alpha)-isomer
Methylprednisolone acetate, (11beta,16beta)-isomer
Methylprednisolone acetic acid
Methylprednisolone-21-acetate
|
|
12 |
|
Gastrointestinal Agents |
|
Phase 4 |
|
|
|
13 |
|
Anti-Retroviral Agents |
|
Phase 4 |
|
|
|
14 |
|
Cobicistat |
Approved |
Phase 3 |
|
1004316-88-4 |
24950485 25151504 |
Synonyms:
1,3-THIAZOL-5-YLMETHYL [(2R,5R)-5-{[(2S)-2-({[(2-ISOPROPYL-1,3-THIAZOL-4-YL)METHYL](METHYL)CARBAMOYL}AMINO)-4-(MORPHOLIN-4-YL)BUTANOYL]AMINO}-1,6-DIPHENYLHEXAN-2-YL]CARBAMATE
COBICISTAT
GS 9350
|
GS-9350
N-[5-({hydroxy[(1,3-thiazol-5-yl)methoxy]methylidene}amino)-1,6-diphenylhexan-2-yl]-2-(N-methyl-N-{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}-(C-hydroxycarbonimidoyl)amino)-4-(morpholin-4-yl)butanimidate
TYBOST
|
|
15 |
|
Darunavir |
Approved |
Phase 3 |
|
635728-49-3, 206361-99-1 |
213039 |
Synonyms:
(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulfanilamido)propyl)carbamate
(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulfanilamido)propyl)carbamic acid
(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulphanilamido)propyl)carbamate
(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulphanilamido)propyl)carbamic acid
(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N1-isobutylsulfanilamido)propyl)carbamate
(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl(1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamATE
(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl(1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamic acid
(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl(1S,2R)-3-[[(4-aminophenyl)sulphonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamate
(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl(1S,2R)-3-[[(4-aminophenyl)sulphonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamic acid
(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate
(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamic acid
(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulphonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate
(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulphonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamic acid
(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate
(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamic acid
(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulphonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate
(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulphonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamic acid
[(S)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamate (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester
[(S)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester
[(S)-3-[(4-Amino-benzenesulphonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamate (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester
[(S)-3-[(4-Amino-benzenesulphonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester
|
{(1S,2R)-3-[(4-amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamate (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester
{(1S,2R)-3-[(4-amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester
{(1S,2R)-3-[(4-amino-benzenesulphonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamate (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester
{(1S,2R)-3-[(4-amino-benzenesulphonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester
114, TMC
AIDS073035
DARUNAVIR
Darunavir ethanolate
Darunavirum
Darunavirum [INN-latin]
Ethanolate, darunavir
MC-114
N-((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl)((1S,2R,5R)-4,6-dioxabicyclo(3.3.0)oct-2-yloxy)carboxamide
N-((1S,2R)-3-(((4-Aminophenyl)sulphonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl)((1S,2R,5R)-4,6-dioxabicyclo(3.3.0)oct-2-yloxy)carboxamide
Prezista
TMC 114
TMC114
TMC-114
TMC-41629
UIC-94017
UIC-940T
|
|
16 |
|
Zidovudine |
Approved |
Phase 3 |
|
30516-87-1 |
35370 |
Synonyms:
3' Azido 2',3' dideoxythymidine
3' Azido 3' deoxythymidine
3'-Azido-2',3'-dideoxythymidine
3'-Azido-3'-deoxythymidine
Antiviral azt
Apo-Zidovudine
Azidothymidine
AZT
AZT (antiviral)
AZT antiviral
AZT, antiviral
Aztec
BW a509U
BWA 509u
BWA509u
|
BWA-509u
BW-A509U
BW-A-509U
COMPOUND S
COMPOUND-S
Novo-Azt
NSC-602670
Retrovir
ZDV
Zidovudin
Zidovudina
Zidovudine
Zidovudine EP III
Zidovudinum
|
|
17 |
|
Pyrimethamine |
Approved, Investigational, Vet_approved |
Phase 3 |
|
58-14-0, 19085-09-7 |
4993 |
Synonyms:
2,4-Diamino-5-(4-chlorophenyl)-6-ethylpyrimidine
2,4-Diamino-5-(p-chlorophenyl)-6-ethylpyrimidine
2,4-Diamino-5-chlorophenyl-6-ethylpyrimidine
5-(4'-Chlorophenyl)-2,4-diamino-6-ethylpyrimidine
5-(4-Chlorophenyl)-6-ethyl-2,4-diaminopyrimidine
5-(4-Chlorophenyl)-6-ethyl-2,4-pyrimidinediamine
Aventis brand OF pyrimethamine
CD
Chloridin
Chloridine
Chloridyn
Darachlor
Daraclor
Darapram
Daraprim
Daraprim®|GNF-Pf-5586|TCMDC-125860
Daraprime
Diaminopyritamin
Disulone
Erbaprelina
Ethylpyrimidine
Fansidar
Glaxo wellcome brand OF pyrimethamine
GlaxoSmithKline brand OF pyrimethamine
GNF-PF-5586
|
Khloridin
Malacid
MALACIDE
Malocid
Malocide
Maloprim
NSC-3061
Pirimecidan
Pirimetamin
Pirimetamina
Primethamine
Pyremethamine
Pyrimethamin
PYRIMETHAMINE
Pyriméthamine
Pyrimethamine Hcl
Pyrimethaminum
RP-4753
TCMDC-123831
TCMDC-125860
Tindurin
Tindurine
Tinduring
Wellcome brand OF pyrimethamine
WR-2978
|
|
18 |
|
Sulfadoxine |
Approved, Investigational |
Phase 3 |
|
2447-57-6 |
17134 |
Synonyms:
4-Sulfanilamido-5,6-dimethoxypyrimidine
4-Sulphanilamido-5,6-dimethoxypyrimidine
Fanasil
FANZIL
J21.373J
RO-44393
RO-4-4393
Roche brand OF sulfadoxine
Sulfadoxina
SULFADOXINE
Sulfadoxine roche brand
Sulfadoxinum
|
Sulformethoxine
Sulformetoxine
SULFORTHAMIDINE
Sulforthomidine
Sulphadoxina
Sulphadoxine
Sulphadoxinum
Sulphormethoxine
Sulphormetoxin
Sulphorthodimethoxine
Sulphorthomidine
WR-4073
|
|
19 |
|
Hydroxychloroquine |
Approved |
Phase 3 |
|
118-42-3 |
3652 |
Synonyms:
(+-)-Hydroxychloroquine
(±)-HYDROXYCHLOROQUINE
2-((4-((7-Chloro-4-quinolyl)amino)pentyl)ethylamino)ethanol
2-(N-(4-(7-Chlor-4-chinolylamino)-4-methylbutyl)ethylamino)ethanol
7-Chloro-4-(4-(ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline
7-Chloro-4-(4-(N-ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline
7-Chloro-4-(4-(N-ethyl-N-b-hydroxyethylamino)-1-methylbutylamino)quinoline
7-Chloro-4-(4-(N-ethyl-N-β-hydroxyethylamino)-1-methylbutylamino)quinoline
7-Chloro-4-[4-(N-ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino]quinoline
7-Chloro-4-[4-(N-ethyl-N-b-hydroxyethylamino)-1-methylbutylamino]quinoline
7-Chloro-4-[4-(N-ethyl-N-β-hydroxyethylamino)-1-methylbutylamino]quinoline
7-Chloro-4-[5-(N-ethyl-N-2-hydroxyethylamino)-2-pentyl]aminoquinoline
Axemal
DOLQUINE
Dolquine®|Plaquenil®
Ercoquin
Gen-Hydroxychloroquine 200mg Tablets
HCQ
Hidroxicloroquina
|
Hidroxicloroquina [inn-spanish]
Hydroxychlorochin
Hydroxychloroguine
HYDROXYCHLOROQUINE
Hydroxychloroquine sulfate
Hydroxychloroquine sulfate (1:1) salt
Hydroxychloroquinum
Hydroxychloroquinum [inn-latin]
Idrossiclorochina [dcit]
NSC4375
Oxichlorochine
Oxichlorochinum
Oxichloroquine
Oxychlorochin
Oxychloroquine
Plaquenil
Polirreumin
Quensyl
|
|
20 |
|
Caspofungin |
Approved |
Phase 3 |
|
179463-17-3, 162808-62-0 |
2826718 |
Synonyms:
(4R,5S)-5-((2-AMINOETHYL)AMINO)-N(2)-(10,12-DIMETHYLTETRADECANOYL)-4-HYDROXY-L-ORNITHYL-L-THREONYL-TRANS-4-HYDROXY-L-PROLYL-(S)-4-HYDROXY-4-(P-HYDROXYPHENYL)-L-THREONYL-THREO-3-HYDROXY-L-ORNITHYL-TRANS-3-HYDROXY-L-PROLINE CYCLIC (6-1)-PEPTIDE
(4R,5S)-5-((2-Aminoethyl)amino)-N(sup 2)-(10,12-dimethyltetradecanoyl)-4-hydroxy-L-ornithyl-L-threonyl-trans-4-hydroxy-L-prolyl-(S)-4-hydroxy-4-(p-hydroxyphenyl)-L-threonyl-threo-3-hydroxy-L-ornithyl-trans-3-hydroxy-L-proline cyclic (6-1)-peptide
(4R,5S)-5-((2-Aminoethyl)amino)-N2-(10,12-dimethyltetradecanoyl)-4-hydroxy-L-ornithyl-L-threonyl-trans-4-hydroxy-L-prolyl-(S)-4-hydroxy-4-(p-hydroxyphenyl)-L-threonyl-threo-3-hydroxy-L-ornithyl-trans-3-hydroxy-L-proline cyclic (1->6) disulfide
1-[(4R,5S)-5-[(2-AMINOETHYL)AMINO]-N(2)-(10,12-DIMETHYL-1-OXOTETRADECYL)-4-HYDROXY-L-ORNITHINE]-5-[(3R)-3-HYDROXY-L-ORNITHINE]-PNEUMOCANDIN B0
Cancidas
Capsofungin
Caspofungin
|
Caspofungin acetate
Caspofungin MSD
Caspofungina
L-743,872
L-743872
MK-991
N-[(3S,6S,9S,11R,15S,20R,21S,24S,25S)-3-[(1R)-3-Amino-1-hydroxypropyl]-21-[(2-aminoethyl)amino]-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-5,8,11,17,20,23,25-heptahydroxy-15-[(1R)-1-hydroxyethyl]-2,14-dioxo-1,4,7,13,16,22-hexaazatricyclo[22.3.0.0⁹,¹³]heptacosa-4,7,16,22-tetraen-18-yl]-10,12-dimethyltetradecanimidate
|
|
21 |
|
Fluconazole |
Approved, Investigational |
Phase 3 |
|
86386-73-4 |
3365 |
Synonyms:
2-(2,4-DIFLUOROPHENYL)-1,3-di(1H-1,2,4-triazol-1-yl)propan-2-ol
2,4-Difluoro-a,a-bis(1H-1,2,4-triazol-1-ylmethyl)benzyl alcohol
2,4-Difluoro-alpha,alpha-bis(1H-1,2,4-triazol-1-ylmethyl)benzyl alcohol
2,4-Difluoro-α,α-bis(1H-1,2,4-triazol-1-ylmethyl)benzyl alcohol
AbZ brand OF fluconazole
Aliud brand OF fluconazole
Alpharma brand OF fluconazole
Apo fluconazole
Apo-fluconazole
Apotex brand OF fluconazole
Armstrong brand OF fluconazole
Béagyne
Betapharm brand OF fluconazole
Biozole
CANESTEN ORAL
Chemia brand OF fluconazole
CT Arzneimittel brand OF fluconazole
CT-Arzneimittel brand OF fluconazole
Diflucan
DIFLUCAN IN SODIUM CHLORIDE
DIFLUCAN ONE
Difluconazole
Effik brand OF fluconazole
Elazor
Fluc hexal
Flucobeta
FlucoLich
Fluconazol
Fluconazol abz
Fluconazol al
Fluconazol isis
|
Fluconazol ratiopharm
Fluconazol stada
Fluconazol von CT
Fluconazole
Fluconazole capsules
FLUCONAZOLE IN SODIUM CHLORIDE
Fluconazol-isis
Fluconazol-ratiopharm
Fluconazolum
Flunazul
Fungata
Hexal brand OF fluconazole
Lavisa
Lesvi brand OF fluconazole
Lichtenstein brand OF fluconazole
Loitin
Mack brand OF fluconazole
Neofomiral
Oxifungol
Pfizer brand OF fluconazole
Pfleger brand OF fluconazole
Ratiopharm brand OF fluconazole
SAT brand OF fluconazole
Silanes brand OF fluconazole
Solacap
Stada brand OF fluconazole
Triflucan
UK-49858
Vita brand OF fluconazole
Zonal
|
|
22 |
|
Posaconazole |
Approved, Investigational, Vet_approved |
Phase 3 |
|
171228-49-2 |
147912 |
Synonyms:
|
23 |
|
Trimetrexate |
Approved, Investigational |
Phase 3 |
|
52128-35-5 |
5583 |
Synonyms:
CI-898
CI-898|Neutrexin®|trimetrexate glucuronate
Hydrate, trimetrexate
Ipsen brand OF trimetrexate
JB 11
JB-11
Monohydrate, monoacetate trimetrexate
Neutrexin
TMQ
|
TMX
TRIMETREXATE
TRIMETREXATE GLUCURONATE
Trimetrexate hydrate
Trimetrexate ipsen brand
Trimetrexate monohydrate, monoacetate
TRIMETREXATO
TRIMETREXATUM
Trimetrexic acid
|
|
24 |
|
Isoniazid |
Approved, Investigational |
Phase 2, Phase 3 |
|
54-85-3 |
3767 |
Synonyms:
4-Pyridinecarbohydrazide
Acid vanillylidenehydrazide, isonicotinic
Andrazide
Antimicina
Antituberkulosum
Armacide
Armazid
Armazide
Atcotibine
Azuren
Bacillin
Cedin
Cemidon
Chemiazid
Chemidon
Cortinazine
Cotinazin
Cotinizin
Defonin
Dibutin
Diforin
Dinacrin
Ditubin
DOW-ISONIAZID
Ebidene
Eralon
Ertuban
Eutizon
Evalon
Fimalene
FSR 3
Ftivazide
GINK
HIA
Hidranizil
Hidrasonil
Hidrulta
Hidrun
Hycozid
Hydrazid
Hydrazide
Hydrazide, isonicotinic acid
Hyozid
HYZYD
Ido-tebin
Idrazil
Inah
INH
Inizid
Iscotin
Isidrina
Ismazide
Isobicina
Isocid
Isocidene
Isocotin
Isohydrazide
Isolyn
Isonerit
Isonex
Isoniacid
Isoniazid
Isoniazid SA
Isoniazida
Isoniazide
Isonicazide
Isonicid
Isonico
Isonicotan
Isonicotil
Isonicotinate hydrazide
Isonicotinhydrazid
Isonicotinic acid hydrazide
Isonicotinic acid vanillylidenehydrazide
Isonicotinic hydrazide
Isonicotinohydrazide
Isonicotinoyl hydrazide
Isonicotinoylhydrazide
Isonicotinsaeurehydrazid
Isonicotinsäurehydrazid
Isonicotinyl hydrazide
Isonicotinyl hydrazine
Isonicotinylhydrazine
Isonide
Isonidrin
Isonikazid
Isonilex
Isonin
Isonindon
Isonirit
Isoniton
Isonizide
|
Isopyrin
Isotamine
Isotebe
Isotebezid
Isotinyl
Isozide
Isozyd
Laniazid
Laniozid
Mybasan
Neoteben
Neo-Tizide
Neoxin
Neumandin
Nevin
Niadrin
Nicazide
Nicetal
Nicizina
Niconyl
Nicotibina
NICOTIBINE
Nicotisan
Nicozide
Nidaton
Nidrazid
Nikozid
Niplen
Nitadon
NSC-9659
NYDRAZID
Nyscozid
Pelazid
Percin
Phthisen
Phthivazid
Phthivazide
Pycazide
Pyreazid
Pyricidin
Pyridicin
Pyridine-4-carboxylate hydrazide
Pyridine-4-carboxylic acid hydrazide
Pyrizidin
Raumanon
Razide
Retozide
Rifamate
Rimicid
RIMIFON
Rimiphone
Rimitsid
Robiselin
Robisellin
Roxifen
Sanohidrazina
Sauterazid
Sauterzid
STANOZIDE
TB-Phlogin
TB-Razide
TB-Vis
Tebecid
Tebenic
Tebexin
Tebilon
Tebos
Teebaconin
Tekazin
Tibazide
Tibemid
Tibison
Tibivis
Tibusan
Tubazid
Tubazide
Tubeco
Tubecotubercid
Tuberian
Tubicon
Tubilysin
Tubomel
Tyvid
Unicocyde
Unicozyde
Vanillylidenehydrazide, isonicotinic acid
Vazadrine
Vederon
Zidafimia
Zinadon
Zonazide
|
|
25 |
|
Rezafungin |
Investigational |
Phase 3 |
|
1396640-59-7 |
|
Synonyms:
|
Rezafungin cation
Rezafungin ion
|
|
26 |
|
Maleic acid |
Experimental, Investigational |
Phase 3 |
|
110-16-7, 110-17-8 |
444266 444972 |
Synonyms:
(2E)-2-Butenedioate
(2E)-2-Butenedioic acid
(2E)-But-2-enedioate
(2E)-But-2-enedioic acid
(2Z)-2-Butenedioate
(2Z)-2-Butenedioic acid
(2Z)-But-2-enedioate
(2Z)-But-2-enedioic acid
(2Z)-Butene-2-dioate
(2Z)-Butene-2-dioic acid
(e)-2-Butenedioate
(e)-2-Butenedioic acid
(Z)-2-Butenedioate
(Z)-2-Butenedioic acid
(Z)-Butenedioate
(Z)-Butenedioic acid
2-(e)-Butenedioate
2-(e)-Butenedioic acid
2-Butenedioate
2-Butenedioic acid
Allomaleate
Allomaleic acid
Boletate
Boletic acid
cis-1,2-Ethylenedicarboxylate
cis-1,2-Ethylenedicarboxylic acid
cis-2-Butenedioate
cis-2-Butenedioic acid
cis-But-2-enedioate
cis-But-2-enedioic acid
cis-Butenedioate
cis-Butenedioic acid
e297
FC 33
Fumarate
Fumaric acid
Fumaricum acidum
Fumarsaeure
|
Fumarsäure
Furamag
H2Male
Hydrogen maleate
Kyselina maleinova
Lichenate
Lichenic acid
MAE
Mafusol
Maleate
MALEIC ACID
Maleic acid, ammonium salt
Maleic acid, calcium salt
Maleic acid, dipotassium salt
Maleic acid, disodium salt
Maleic acid, iron salt
Maleic acid, monoammonium salt
Maleic acid, monocopper (2+) salt
Maleic acid, monosodium salt
Maleic acid, neodymium salt
Maleic acid, potassium salt
Maleic acid, sodium salt
Maleinic acid
Malenic acid
Malezid CM
Scotchbond multipurpose etchant
Sodium maleate
Toxilate
Toxilic acid
trans-1,2-Ethylenedicarboxylate
trans-1,2-Ethylenedicarboxylic acid
trans-2-Butenedioate
trans-2-Butenedioic acid
trans-But-2-enedioate
trans-But-2-enedioic acid
trans-Butenedioate
trans-Butenedioic acid
|
|
27 |
|
Pafuramidine |
Investigational |
Phase 3 |
|
186953-56-0 |
459963 |
Synonyms:
2,5-Bis(4-amidinophenyl)furan-bis-O-methylamidoxime
DB289 CPD
|
|
|
28 |
|
HIV Protease Inhibitors |
|
Phase 3 |
|
|
|
29 |
|
Cobicistat mixture with darunavir |
|
Phase 3 |
|
|
|
30 |
|
Cytochrome P-450 CYP3A Inhibitors |
|
Phase 3 |
|
|
|
31 |
|
protease inhibitors |
|
Phase 3 |
|
|
|
Synonyms:
|
32 |
|
Antiviral Agents |
|
Phase 3 |
|
|
|
33 |
|
Anti-HIV Agents |
|
Phase 3 |
|
|
|
34 |
|
Reverse Transcriptase Inhibitors |
|
Phase 3 |
|
|
|
35 |
|
Antirheumatic Agents |
|
Phase 3 |
|
|
|
36 |
|
Echinocandins |
|
Phase 3 |
|
|
|
37 |
|
Pharmaceutical Solutions |
|
Phase 3 |
|
|
|
38 |
|
Vitamins |
|
Phase 3 |
|
|
|
39 |
|
Trace Elements |
|
Phase 3 |
|
|
|
40 |
|
Antimetabolites |
|
Phase 3 |
|
|
|
41 |
|
Antidotes |
|
Phase 3 |
|
|
|
42 |
|
Calcium, Dietary |
|
Phase 3 |
|
|
|
43 |
|
Micronutrients |
|
Phase 3 |
|
|
|
44 |
|
Hypolipidemic Agents |
|
Phase 2, Phase 3 |
|
|
|
45 |
|
Lipid Regulating Agents |
|
Phase 2, Phase 3 |
|
|
|
46 |
|
Calcium |
Nutraceutical |
Phase 3 |
|
7440-70-2 |
271 |
Synonyms:
Ca
Ca(2+)
Ca2+
Calcio
CALCIUM
Calcium element
|
CALCIUM ion
Calcium(2+)
Calcium, doubly charged positive ion
Calcium, elemental
Elemental calcium
Kalzium
|
|
47 |
|
Phylloquinone |
Approved, Investigational |
Phase 2 |
|
84-80-0 |
5284607 |
Synonyms:
(2S)-2-(Henicosanoyloxy)-3-(tridecanoyloxy)propyl (7Z,10Z,19Z)-docosa-4,7,10,13,16,19-hexaenoic acid
2',3'-trans-Vitamin K1
2’,3’-trans-vitamin K1
2-Methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-1,4-naphthalenedione
2-Methyl-3-[(2E)-3,7,11,15-tetramethyl-2-hexadecenyl]naphthoquinone
2-METHYL-3-[(2E)-3,7,11,15-TETRAMETHYLHEXADEC-2-EN-1-YL]-1,4-DIHYDRONAPHTHALENE-1,4-DIONE
2-METHYL-3-[(2E,7R,11R)-3,7,11,15-TETRAMETHYLHEXADEC-2-EN-1-YL]NAPHTHALENE-1,4-DIONE
2-methyl-3-[(E,7R,11R)-3,7,11,15-tetramethylhexadec-2-enyl]naphthalene-1,4-dione
2-METHYL-3-PHYTHYL-1,4-NAPHTHOCHINON
2-Methyl-3-phytyl-1,4-naphthochinon
2-Methyl-3-phytyl-1,4-naphthoquinone
2-METHYL-3-PHYTYL-1,4-NAPTHOQUINONE
3-Phytylmenadione
alpha-Phylloquinone
ANTIHEMORRHAGIC VITAMIN
a-Phylloquinone
AQUA MEPHYTON
AQUA-MEPHYTIN
Aquamephyton
COMBINAL K1
Fitomenadiona
FITOMENADIONE
KANAVIT
KATIV N
KEPHTON
KINADION
K-JECT
|
Konakion
KONAKION MM
KONAKION MM PAED
MEPHYTON
MONODION
MONO-KAY
NEOKAY
NSC-270681
ORAKAY
Phyllochinon
Phyllochinonum
Phyllohydroquinone
Phylloquinone
PHYLLOQUINONE E-FORM
PHYTHYL-MENADION
Phytomenadione
Phytomenadionum
Phytonadione
Phytonadionum
Phytylmenadione
SYNTHEX P
trans-Phylloquinone
VITAMIN K
Vitamin K 1
Vitamin K hydroquinone (phylloquinone)
Vitamin K1
Α-phylloquinone
|
|
48 |
|
Azithromycin |
Approved |
Phase 2 |
|
83905-01-5 |
447043 |
Synonyms:
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
Azadose
AZASITE
Azenil
Azifast
Azigram
Azimakrol
Azithramycine
AZITHROMYCIN
AZITHROMYCIN ANHYDROUS
Azithromycin dihydrate
AZITHROMYCIN HYDRATE
Azithromycin monohydrate
Azithromycin pfizer brand
Azithromycine
Azithromycinum
Azitrocin
Azitromicina
Azitromin
AZYTER
Azythromycin
Bayer brand OF azithromycin dihydrate
CLAMELLE
CP 62993
|
CP-62,993
CP-62993
Dihydrate, azithromycin
Funk brand OF azithromycin dihydrate
Goxal
Hemomycin
Lesvi brand OF azithromycin dihydrate
Mack brand OF azithromycin dihydrate
Monohydrate, azithromycin
Pfizer brand OF azithromycin
Pfizer brand OF azithromycin dihydrate
Pharmacia brand OF azithromycin dihydrate
Sumamed
SUNAMED
Toraseptol
Ultreon
Vinzam
Vita brand OF azithromycin dihydrate
XZ 405
XZ 450
XZ-450
Zentavion
Zithromax
Zitromax
Zmax
|
|
49 |
|
Menadione |
Approved, Nutraceutical |
Phase 2 |
|
58-27-5 |
4055 |
Synonyms:
2-METHYL-1,4-DIHYDRONAPHTHALENE-1,4-DIONE
2-Methyl-1,4-naftochinon
2-Methyl-1,4-naphthalendione
2-Methyl-1,4-naphthalenedione
2-Methyl-1,4-naphthochinon
2-Methyl-1,4-naphthodione
2-Methyl-1,4-naphthoquinone
2-Methylnaphthoquinone
3-Methyl-1,4-naphthoquinone
Aquakay
Aquinone
Bisulfite, menadione
Bisulfite, menadione sodium
Hemodal
Juva-K
Kaergona
Kanone
Kappaxan
Kappaxin
Karcon
Kareon
Kativ-g
Kayklot
Kaykot
Kaynone
Kayquinone
Kipca
Kipca-oil soluble
Klottone
Koaxin
Kolklot
|
K-Thrombyl
K-Vitan
Menadion
MENADIONE
Menadione bisulfite
Menadione sodium bisulfite
Menadione sodium bisulfite, trihydrate
Menaphthene
Menaphthon
Menaphthone
Menaphtone
Menaquinone
Menaquinone O
Mitenon
Mitenone
MNQ
NSC-4170
Panosine
Prokayvit
Sodium bisulfite, menadione
Synkay
Thyloquinone
Vicasol
Vikasol
Vitamin K 3
Vitamin K0
Vitamin K2
Vitamin K3
Vitamin K3 sodium bisulfite
Vitamin K3: 1,4-dihydro-1,4-dioxo-2-methylnaphthalene
|
|
50 |
|
Menaquinone |
Investigational |
Phase 2 |
|
1182-68-9 |
|
Interventional clinical trials:
(show top 50)
(show all 85)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
A Prospective Randomized Controlled Study to Compare Efficacy of Caspofungin Combined With Trimethoprim-sulfamethoxazole Versus Trimethoprim/Sulfamethoxazole as First-line Therapy in Non-HIV Patients With Severe Pneumocystis Pneumonia |
Unknown status |
NCT03978559 |
Phase 4 |
caspofungin;TMP/SMZ(trimethoprim/sulfisoxazole);Methylprednisolone |
2 |
A Phase IV, Randomised, Multicentre, Double-blind, Study to Evaluate the Clinical Utility of Prospective Genetic Screening (HLA-B*1301) for Susceptibility to Dapsone Hypersensitivity Syndrome |
Unknown status |
NCT02550080 |
Phase 4 |
Dapsone |
3 |
Gradual Initiation of Trimethoprim/Sulfamethoxazole as Primary Pneumocystis Carinii Pneumonia Prophylaxis |
Completed |
NCT00000816 |
Phase 4 |
Sulfamethoxazole-Trimethoprim |
4 |
Randomized Clinical Trial to Assess Whether the Duration of Cotrimoxazole Preventive Therapy in HIV Patients With CD4 Counts >350 CD4 Cells/µL by Antiretroviral Treatment Influences the Rate of Carriage of Multidrug-resistant Bacteria |
Completed |
NCT03087890 |
Phase 4 |
Cotrimoxazole;Placebo |
5 |
Oral Corticosteroids Therapy and Interstitial Fibrosis in Patients With Pneumocystis Jirovecii Pneumonia (PCP) and pO2 of >70 at Presentation. |
Withdrawn |
NCT00636935 |
Phase 4 |
Antibiotics only;Antibiotics + Corticosteroids;Corticosteroids + antibiotics |
6 |
The Safety and Effectiveness of Trimethoprim/Sulfamethoxazole as Pneumocystis Carinii Pneumonia (PCP) Prophylaxis in Patients With Connective Tissue Diseases |
Unknown status |
NCT01747278 |
Phase 2, Phase 3 |
Trimethoprim/Sulfamethoxazole |
7 |
Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19 |
Unknown status |
NCT04252274 |
Phase 3 |
Darunavir and Cobicistat |
8 |
Intérêt de la corticothérapie Dans la Pneumocystose Grave du Patient immunodéprimé Non VIH. Essai Prospectif Multicentrique Randomisé Contrôlé : PIC |
Unknown status |
NCT02944045 |
Phase 3 |
Methylprednisolone;Placebo |
9 |
A Study of Trimetrexate With Leucovorin Rescue for AIDS Patients Who Are Refractory to Standard Therapies for Pneumocystis Carinii Pneumonia |
Completed |
NCT00000724 |
Phase 3 |
Trimetrexate glucuronate;Leucovorin calcium |
10 |
A Randomized, Comparative, Double-Blind Trial of Trimetrexate (CI-898) With Leucovorin Calcium Rescue Versus Trimethoprim / Sulfamethoxazole for Moderately Severe Pneumocystis Carinii Pneumonia in Patients With AIDS |
Completed |
NCT00001013 |
Phase 3 |
Trimetrexate glucuronate;Pentamidine isethionate;Sulfamethoxazole-Trimethoprim;Leucovorin calcium |
11 |
A Randomized, Open-Label Trial of High Dose Atovaquone Versus Low Dose Atovaquone Versus Aerosolized Pentamidine for Prophylaxis of Pneumocystis Carinii Pneumonia in Patients With HIV Infection Who Are Intolerant of TMP/SMX |
Completed |
NCT00002340 |
Phase 3 |
Atovaquone;Pentamidine isethionate |
12 |
A Treatment Protocol for the Use of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia and Serious Intolerance to Approved Therapies |
Completed |
NCT00001016 |
Phase 3 |
Trimetrexate glucuronate;Leucovorin calcium |
13 |
A Controlled Comparative Trial of Trimethoprim - Sulfamethoxazole Versus Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients Receiving Azidothymidine (AZT) |
Completed |
NCT00000727 |
Phase 3 |
Pentamidine isethionate;Pyrimethamine;Sulfamethoxazole/Trimethoprim;Sulfadoxine/Pyrimethamine;Zidovudine |
14 |
A Randomized, Comparative, Double-Blind Trial of Trimetrexate (CI-898) With Leucovorin Calcium Rescue Versus Trimethoprim / Sulfamethoxazole for Moderately Severe Pneumocystis Carinii Pneumonia in Patients With AIDS |
Completed |
NCT00001014 |
Phase 3 |
Trimetrexate glucuronate;Sulfamethoxazole-Trimethoprim;Leucovorin calcium |
15 |
An Open, Prospective, Multicenter Study of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia (PCP) and Serious Intolerance to Approved Therapies |
Completed |
NCT00000714 |
Phase 3 |
Trimetrexate glucuronate;Leucovorin calcium |
16 |
A Controlled Trial Comparing the Efficacy of Aerosolized Pentamidine and Parenteral/Oral Trimethoprim-Sulfamethoxazole in the Treatment of Pneumocystis Pneumonia in AIDS |
Completed |
NCT00000715 |
Phase 3 |
Pentamidine isethionate;Sulfamethoxazole-Trimethoprim |
17 |
A Randomized, Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant of Trimethoprim and/or Sulfonamides |
Completed |
NCT00000802 |
Phase 3 |
Atovaquone;Dapsone |
18 |
A Randomized Trial of Three Anti-Pneumocystis Agents Plus Zidovudine for the Primary Prevention of Serious Infections in Patients With Advanced HIV Infection |
Completed |
NCT00000991 |
Phase 3 |
Pentamidine isethionate;Sulfamethoxazole-Trimethoprim;Dapsone;Zidovudine |
19 |
A Randomized, Comparative, Prospective Study of Monthly Aerosolized Pentamidine and Thrice Weekly Dapsone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant to Trimethoprim and/or Sulfonamides |
Completed |
NCT00001028 |
Phase 3 |
Pentamidine isethionate;Dapsone |
20 |
A Phase III Comparative Study of Dapsone / Trimethoprim and Clindamycin / Primaquine Versus Trimethoprim / Sulfamethoxazole in the Treatment of Mild-to-Moderate PCP in Patients With AIDS |
Completed |
NCT00000640 |
Phase 3 |
Primaquine;Sulfamethoxazole-Trimethoprim;Dapsone;Clindamycin |
21 |
A Randomized, Comparative, Prospective Study of Daily Trimethoprim / Sulfamethoxazole (TMS) and Thrice-Weekly TMS for Prophylaxis Against PCP in HIV-Infected Patients |
Completed |
NCT00000748 |
Phase 3 |
Sulfamethoxazole-Trimethoprim |
22 |
Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19 |
Completed |
NCT04261517 |
Phase 3 |
Hydroxychloroquine |
23 |
A Phase 3, Multicenter, Randomized, Double-Blind Study of the Efficacy and Safety of Rezafungin for Injection Versus the Standard Antimicrobial Regimen to Prevent Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation (The ReSPECT Study) |
Recruiting |
NCT04368559 |
Phase 3 |
Rezafungin for Injection;Posaconazole;Fluconazole;Trimethoprim-sulfamethoxazole (TMP/SMX);Intravenous Placebo;Oral Placebo |
24 |
Low Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Jirovecii Pneumonia |
Not yet recruiting |
NCT04851015 |
Phase 3 |
trimethoprim-sulfamethoxazole |
25 |
International Randomized, Controlled Phase 3 Trial of DB289 Versus Trimethoprim-sulfamethoxazole for the Treatment of Acute Pneumocystis Jiroveci Pneumonia (PCP) in Patients With HIV/AIDS |
Terminated |
NCT00302341 |
Phase 3 |
Pafuramidine maleate (DB289);Trimethoprim-Sulfamethoxazole (TMP-SMX) |
26 |
A Randomized, Comparative Trial of Trimetrexate With Leucovorin Rescue Versus Standard Anti-Pneumocystis Therapy Versus Standard Anti-Pneumocystis Therapy With High Dose Steroids for AIDS Patients With Pneumocystis Pneumonia Who Appear to Be Refractory to Conventional Drugs |
Terminated |
NCT00000730 |
Phase 3 |
Trimetrexate glucuronate;Methylprednisolone;Pentamidine isethionate;Sulfamethoxazole-Trimethoprim;Leucovorin calcium |
27 |
A Randomized, Double Blind, Placebo Controlled Trial to Determine the Efficacy of Isoniazid (INH) in Preventing Tuberculosis Disease and Latent Tuberculosis Infection Among Infants With Perinatal Exposure to HIV |
Terminated |
NCT00080119 |
Phase 2, Phase 3 |
Isoniazid (INH);Trimethoprim/Sulfamethoxazole (TMP/SMX);Isoniazid Placebo (PL) |
28 |
A Controlled Randomized Trial to Study the Efficacy of Adjunctive Methylprednisolone for the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Pediatric AIDS Patients |
Withdrawn |
NCT00000741 |
Phase 3 |
Methylprednisolone |
29 |
A Randomized, Double-Blind Study of 566C80 Versus Septra (Trimethoprim/Sulfamethoxazole) for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients |
Completed |
NCT00000655 |
Phase 2 |
Atovaquone;Sulfamethoxazole-Trimethoprim |
30 |
A Phase II Study of WR 6026 for Pneumocystis Carinii Pneumonia in People With HIV Infection |
Completed |
NCT00000863 |
Phase 2 |
Sitamaquine |
31 |
A Phase II Open Randomized Comparison of 566C80 and Pentamidine Isethionate for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients Who Are Intolerant of Trimethoprim / Sulfamethoxazole |
Completed |
NCT00001996 |
Phase 2 |
Atovaquone;Pentamidine isethionate |
32 |
A Randomized, Phase II/III, Double-Blind, Two-Armed Study of Micronized Atovaquone and Azithromycin (AT/AZ) as Compared to Trimethoprim-Sulfamethoxazole (TMP/SMX) in the Prevention of Serious Bacterial Infections When Used in Children Aged 3 Months to 19 Years With HIV Infection |
Completed |
NCT00000811 |
Phase 2 |
Azithromycin;Atovaquone;Sulfamethoxazole-Trimethoprim |
33 |
Comparison of Two Dosage Regimens of Oral Dapsone for Prophylaxis of Pneumocystis Carinii Pneumonia in Pediatric HIV Infection |
Completed |
NCT00000739 |
Phase 1 |
Dapsone |
34 |
Evaluation of Escalating Doses of Intravenous Trimetrexate as Therapy for Previously Untreated Pneumocystis Carinii Pneumonia in AIDS Patients With Subsequent Comparison of Intravenous and Oral Pharmacokinetics |
Completed |
NCT00000998 |
Phase 1 |
Trimetrexate glucuronate;Leucovorin calcium |
35 |
Randomized Phase I Study of Trimetrexate Glucuronate (TMTX) With Leucovorin (LCV) Protection Plus Dapsone Versus Trimethoprim / Sulfamethoxazole (TMP/SMX) for Treatment of Moderately Severe Episodes of Pneumocystis Carinii Pneumonia |
Completed |
NCT00002120 |
Phase 1 |
Trimetrexate glucuronate;Trimethoprim;Sulfamethoxazole;Dapsone;Leucovorin calcium |
36 |
A Phase I Study of the Safety, Tolerance, and Study of the Pharmacokinetics of Aerosolized Pentamidine and Parenteral Pentamidine in Children With HIV Infection and Suspected Pneumocystis Carinii Pneumonia |
Completed |
NCT00000974 |
Phase 1 |
Pentamidine isethionate |
37 |
A Phase I/II Trial of Parenteral Pentamidine for PCP Prophylaxis in HIV-Infected Children Who Are Intolerant to Oral Trimethoprim-Sulfamethoxazole |
Completed |
NCT00001027 |
Phase 1 |
Pentamidine isethionate |
38 |
Escalating Multiple-Dose Safety and Tolerance of WR 6026 Hydrochloride in HIV-Infected Subjects |
Completed |
NCT00000740 |
Phase 1 |
Sitamaquine |
39 |
Phase I Safety and Pharmacokinetics Study of Microparticulate Atovaquone (m-Atovaquone; 566C80) in HIV-Infected and Perinatally Exposed Infants and Children |
Completed |
NCT00000773 |
Phase 1 |
Atovaquone |
40 |
A Pharmacokinetic and Pharmacogenetic Study in Patients Receiving Sulfamethoxazole-trimethoprim Therapy |
Unknown status |
NCT02045160 |
|
|
41 |
Effects and Safety of Caspofungin and Corticosteroids in Pneumocystis Pneumonia in Non-HIV Patients |
Unknown status |
NCT02603575 |
|
caspofungin;corticosteroids;Sulfanilamides |
42 |
Prospective Registration of Severe Pneumocystis Jiroveci Pneumonia Requiring ICU |
Unknown status |
NCT03201497 |
|
|
43 |
Assessment of the Safety and Intravenous Pentamidine for Pneumocystis Jirovecii Pneumonia in Patients With Hematologic Malignancies and Stem Cell Transplant Recipients. |
Completed |
NCT02669706 |
|
Pentamidine |
44 |
Clindamycin - Trimethoprim/Sulfamethoxazole for Pneumocystis Jiroveci Pneumonia After Solid Organ Transplantation Population (CTSTOP) |
Completed |
NCT04328688 |
|
|
45 |
A Study of Neutrexin (Trimetrexate Glucuronate) With Leucovorin Protection for Pediatric Patients (Ages 2-12) With Pneumocystis Carinii Pneumonia |
Completed |
NCT00002317 |
|
Trimetrexate glucuronate;Leucovorin calcium |
46 |
A Double-Blind Group Comparative Study To Evaluate the Safety and Effectiveness of Three Different Doses of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in Patients With AIDS Post First Episode PCP |
Completed |
NCT00002291 |
|
Pentamidine isethionate |
47 |
Randomized Prospective Study of Dapsone Versus Trimethoprim-Sulfamethoxazole in the Treatment of First Episode Pneumocystis Carinii Pneumonia in AIDS Patients |
Completed |
NCT00002283 |
|
Trimethoprim;Sulfamethoxazole;Dapsone |
48 |
Lipid-Based Parenteral Nutritional Support in Patients With the Acquired Immunodeficiency Syndrome and Pneumocystis Carinii Pneumonia. A Comparison of Two Lipid Formulations |
Completed |
NCT00002275 |
|
Fat Emulsion 2%;Fat Emulsion 20% |
49 |
A Compassionate Treatment Protocol for the Use of Trimetrexate Glucuronate With Leucovorin Protection for Patients With Pneumocystis Carinii Pneumonia. |
Completed |
NCT00002102 |
|
Trimetrexate glucuronate;Leucovorin calcium |
50 |
The Safety and Efficacy of Clindamycin and Primaquine in the Treatment of Mild - Moderate Pneumocystis Carinii Pneumonia in Patients With AIDS |
Completed |
NCT00000717 |
|
Primaquine;Clindamycin |
Inferred drug relations via
UMLS
71
/
NDF-RT
50
:
Atovaquone
CLINDAMYCIN PHOSPHATE PWDR
Pentamidine
Pentamidine Isethionate
|
Sulfadoxine
TRIMETHOPRIM SULFATE
Trimetrexate
|
|